Φορτώνει......
Impact of obinutuzumab alone and in combination for follicular lymphoma
Although rituximab-based chemoimmunotherapy prolongs the survival of patients with follicular lymphoma (FL), this disease is considered incurable in most patients. Thus, new therapies are needed not only for those in the relapsed/refractory setting, but also for initial treatment. Obinutuzumab (G, G...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Blood Lymphat Cancer |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6467363/ https://ncbi.nlm.nih.gov/pubmed/31360086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S114173 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|